Metformin to Treat Obesity in Children With Insulin Resistance

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

August 31, 2009

Study Completion Date

May 31, 2011

Conditions
HyperinsulinemiaObesity
Interventions
DRUG

Metformin HCL

Medication studied for ability to alter body weight and body composition.

DRUG

Placebo

Control capsules for metformin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Jack Yanovski, M.D.

NIH

NCT00005669 - Metformin to Treat Obesity in Children With Insulin Resistance | Biotech Hunter | Biotech Hunter